Concepedia

T. Khanh

TK

Statistics

Publications

44

Citations

3.9K

H-Index

32

Active since

1999

Affiliations

Dana-Farber Cancer Institute(Current)

National Cancer Institute

Center for Cancer Research

Massachusetts General Hospital

Brigham and Women's Hospital

T. Khanh is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1999–2024

44

Publications

44

Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Sarah J. Hill, Brennan Decker, Emma A. Roberts et al. · Cancer Discovery · 2018 · 457 citations · Full text

, , +17

Institutional implementation of clinical tumor profiling on an unselected cancer population

Lynette M. Sholl, T. Khanh, Priyanka Shivdasani et al. · JCI Insight · 2016 · 448 citations · Full text

, , +16

Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors

T. Khanh, Deborah Wilsker, Jiuping Ji et al. · Journal of Clinical Oncology · 2015 · 322 citations · Full text

, , +13

Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation

Sally A. Amundson, T. Khanh, Sohrab Shahab et al. · Radiation Research · 2000 · 292 citations

, , +15

Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen

Sally A. Amundson, T. Khanh, Lisa C. Vinikoor et al. · Cancer Research · 2008 · 251 citations

, , +17

1–5 of 44